We are live on ! Find out more
NED

Nancy E. Dempze Portfolio holdings

AUM $182M
1-Year Est. Return 16.09%
This Fund
S&P 500
This Quarter Est. Return
+3.63%
1 Year Est. Return
+16.09%
3 Year Est. Return
+59.1%
5 Year Est. Return
+78.95%
10 Year Est. Return
+300.76%
AUM
$146M
AUM Growth
+$14.4M
Cap. Flow
+$11M
Cap. Flow %
7.56%
Top 10 Hldgs %
38.97%
Holding
81
New
19
Increased
31
Reduced
18
Closed
–

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$1.34M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.07M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$815K
4
BALL icon
Ball Corp
BALL
+$607K
5
MKC icon
McCormick & Company Non-Voting
MKC
+$606K

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$1.02M
2
NVS icon
Novartis
NVS
+$628K
3
NVDA icon
NVIDIA
NVDA
+$550K
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$125K
5
PG icon
Procter & Gamble
PG
+$109K

Sector Composition

Rank Sector Weight
1 Technology 28.64%
2 Healthcare 17.91%
3 Industrials 11.49%
4 Consumer Discretionary 9.89%
5 Financials 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
26
Medtronic
MDT
$112B
$1.36M 0.93%
17,234
-70
-0.4% -$5.74K
BRK.B icon
27
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.28M 0.88%
3,156
+1,355
+75% +$554K
CARR icon
28
Carrier Global
CARR
$49.4B
$1.27M 0.87%
20,185
+9,790
+94% +$601K
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$123B
$1.21M 0.83%
2,583
+1,878
+266% +$815K
REGN icon
30
Regeneron Pharmaceuticals
REGN
$72.9B
$1.16M 0.79%
+1,100
New +$1.07M
BALL icon
31
Ball Corp
BALL
$17.5B
$1.15M 0.79%
19,149
+9,059
+90% +$607K
VIG icon
32
Vanguard Dividend Appreciation ETF
VIG
$111B
$1.14M 0.78%
6,231
– –
JPM icon
33
JPMorgan Chase
JPM
$916B
$1.03M 0.71%
5,088
+1,530
+43% +$299K
WM icon
34
Waste Management
WM
$95B
$899K 0.62%
4,212
-178
-4% -$37K
IWV icon
35
iShares Russell 3000 ETF
IWV
$19.2B
$649K 0.45%
2,102
– –
MKC icon
36
McCormick & Company Non-Voting
MKC
$14B
$591K 0.41%
+8,325
New +$606K
MRK icon
37
Merck
MRK
$322B
$545K 0.37%
4,405
+1,000
+29% +$129K
ITW icon
38
Illinois Tool Works
ITW
$84.1B
$457K 0.31%
+1,930
New +$477K
GOOG icon
39
Alphabet (Google) Class C
GOOG
$4.11T
$448K 0.31%
2,445
-10
-0.4% -$1.7K
CB icon
40
Chubb
CB
$140B
$408K 0.28%
+1,600
New +$411K
XOM icon
41
ExxonMobil
XOM
$650B
$394K 0.27%
3,425
+1,000
+41% +$116K
NKE icon
42
Nike
NKE
$64.1B
$389K 0.27%
5,162
-10,947
-68% -$1.02M
HON icon
43
Honeywell
HON
$76.4B
$379K 0.26%
1,883
-27
-1% -$5.14K
NVS icon
44
Novartis
NVS
$302B
$376K 0.26%
3,532
-6,255
-64% -$628K
WFC icon
45
Wells Fargo
WFC
$254B
$374K 0.26%
+6,302
New +$372K
CL icon
46
Colgate-Palmolive
CL
$74.8B
$359K 0.25%
+3,700
New +$341K
SBUX icon
47
Starbucks
SBUX
$119B
$343K 0.24%
+4,410
New +$359K
PEP icon
48
PepsiCo
PEP
$196B
$308K 0.21%
1,870
-125
-6% -$21.6K
CINF icon
49
Cincinnati Financial
CINF
$27.8B
$307K 0.21%
+2,600
New +$305K
ABBV icon
50
AbbVie
ABBV
$465B
$305K 0.21%
1,780
+667
+60% +$110K
1
2
3

Similar funds

RS
R Squared Central, Hong Kong $182M AUM 18.52% 1-Year Est. Return
CFG
Cosner Financial Group Windsor, Colorado $182M AUM 12.93% 1-Year Est. Return
CFG
Capital Financial Group Greenwood Village, Colorado $182M AUM
TFP
Tilia Fiduciary Partners Wilmington, North Carolina $182M AUM 18.85% 1-Year Est. Return
AFS
Anderson Financial Strategies Dayton, Ohio $182M AUM 13.12% 1-Year Est. Return
EMB
Elefante Mark B $182M AUM 17.71% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
HWM
HFG Wealth Management The Woodlands, Texas $182M AUM 14.4% 1-Year Est. Return

Nancy E. Dempze's Q2 2024 Portfolio in Review

As of Q2 2024, Nancy E. Dempze held 81 positions worth $146M, up 11% from $131M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Nancy E. Dempze deployed $11M of net new capital in Q2 2024, opening 19 new positions and adding to 31 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 1,100 shares worth $1.16M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Nike, an estimated $1.02M trimmed.

  • Nancy E. Dempze's largest Q2 2024 buy was Regeneron Pharmaceuticals: 1,100 shares worth $1.16M.
  • Nancy E. Dempze added most to Visa in Q2 2024, an estimated $1.34M increase.
  • Nancy E. Dempze's biggest Q2 2024 reduction was Nike, cutting an estimated $1.02M.
  • Nancy E. Dempze's ten largest holdings make up 39% of its $146M portfolio in Q2 2024.
  • Nancy E. Dempze opened 19 new positions and closed 0 in Q2 2024.
  • Nancy E. Dempze's portfolio value rose 11% quarter-over-quarter to $146M.

Based on Nancy E. Dempze's 13F filing for Q2 2024, filed 12 Aug 2024.